Use of in vitro data in PBPK models: An example of in vitro to in vivo extrapolation with carbaryl

ACS Symposium Series

Volumn 1099, Issue , 2012, Pages 323-338

  Yoon, Miyoung ^a   Kedderis, Gregory L ^b   Yang, Yuching ^a   Allen, Bruce C ^c   Yan, Grace Z ^a   Clewell, Harvey J ^a  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b Independent Consultant   (United States)

^c Bruce Allen Consulting   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTATIONAL CHEMISTRY; EXTRAPOLATION; RATS; RISK ASSESSMENT;

CHOLINESTERASES (CHES); ENVIRONMENTAL CHEMICALS; INTESTINAL ABSORPTION; KINETIC DATA; MODEL APPROACH; PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS; SCALING PROCESS; UNCERTAIN PARAMETERS;

INSECTICIDES;

EID: 84905638162     PISSN: 00976156     EISSN: 19475918     Source Type: Book Series    
DOI: 10.1021/bk-2012-1099.ch020     Document Type: Conference Paper

References (33)

1. Andersen, M. E.; Krewski, D. Toxicity testing in the 21st century: Bringing the vision to life. Toxicol. Sei. 2009, 707(2), 324-30.
2. Kedderis, G. L. In Vitro to In Vivo Extrapolation of Metabolic Rate Constants for Physiologically Based Pharmacokinetic Models. In Toxicokinetics and Risk Assessment; Lipscomb, J. C, Ohanian, E. V, Eds.; Informa Healthcare: New York, 2007; pp 185-210.
3. Lipscomb, J. C.; Poet, T. S. In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacol. Ther. 2008, 118 (1), 82-103.
4. Knaak, J. B.; Dary, C. C.; Okino, M. S.; Power, F. W.; Zhang, X.; Thompson, C. B.; Tornero-Velez, R.; Blancato, J. N. Parameters for carbamate pesticide QS AR and PBPK/PD models for human risk assessment. Rev. Environ. Contam. Toxicol. 2008, 193, 53-212.
5. Foxenberg, R. J.; Ellison, C. A.; Knaak, J. B.; Ma, C.; Olson, J. R. Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: Chlorpyrifos and parathion. Toxicology 2011, 285 (1-2), 57-66.
6. Mirfazaelian, A.; Kim, K. B.; Anand, S. S.; Kim, H. J.; Tornero-Velez, R.; Bruckner, J. V.; Fisher, J. W. Development of a physiologically based pharmacokinetic model for deltamethrin in the adult male Sprague-Dawley rat. Toxicol. Sei. 2006, 93 (2), 432-12.
7. Anand, S. S.; Bruckner, J. V.; Haines, W. T.; Muralidhara, S.; Fisher, J. W.; Padilla, S. Characterization of deltamethrin metabolism by rat plasma and liver microsomes. Toxicol. Appl. Pharmacol. 2006, 272(2), 156-66.
8. Foxenberg, R. J.; McGarrigle, B. P.; Knaak, J. B.; Kostyniak, P. J.; Olson, J. R. Human hepatic cytochrome p450-specific metabolism of parathion and chlorpyrifos. DrugMetab. Dispos. 2007, 35(2), 189-93.
9. Usmani, K. A.; Hodgson, E.; Rose, R. L. In vitro metabolism of carbofuran by human, mouse, and rat cytochrome P450 and interactions with chlorpyrifos, testosterone, and estradiol. Chem. Biol. Interact. 2004, 150(3), 221-32.
10. Sogorb, M. A.; Vilanova, E. Enzymes involved in the detoxification of organophosphorus, carbamate and pyrethroid insecticides through hydrolysis. Toxicol. Lett. 2002, 128 (1-3), 215-28.
11. Tang, J.; Cao, Y.; Rose, R. L.; Hodgson, E. In vitro metabolism of carbaryl by human cytochrome P450 and its inhibition by chlorpyrifos. Chem. Biol. Interact. 2002, 141 (3), 229-41.
12. Knaak, J. B.; Tallant, M. J.; Kozbelt, S. J.; Sullivan, L. J. The metabolism of carbaryl in the rat, guinea pig, and man. J. Agric. Food Chem. 1965, 13 (6), 537-543.
13. Knaak, J. B.; Tallant, M. J.; Kozbelt, S. J.; Sullivan, L. J. The metabolism of carbaryl in man, monkey, pig, and sheep. J. Agric. Food Chem. 1968, 16 (3), 465-470.
14. Nong, A.; Tan, Y. M.; Krolski, M. E.; Wang, J.; Lunchick, C.; Conolly, R. B.; Clewell, H. J., 3rd Bayesian calibration of a physiologically based pharmacokinetic/pharmacodynamic model of carbaryl Cholinesterase inhibition. J. Toxicol. Environ. Health, Part A 2008, 71 (20), 1363-81.
15. Yoon, M.; Kedderis, G.; Tan, Y.-M.; Clewell, H. Using in vitro pharmacokinetic and pharmacodynamic data to refine the pharmacokinetic model for carbaryl in the rat. The Toxicologist CD-An official Journal of the Society of Toxicology 2010, 114, Abstract #895.
16. Gomez-Lechon, M. J.; Donate, M. T.; Castell, J. V.; Jover, R. Human hepatocytes as a tool for studying toxicity and drug metabolism. Curr Drug Metab. 2003, 4 (4), 292-312.
17. Hewitt, N. J.; Lechon, M. J.; Houston, J. B.; Hallifax, D.; Brown, H. S.; Maurel, P.; Kenna, J. G.; Gustavsson, L.; Lohmann, C.; Skonberg, C.; Guillouzo, A.; Tuschl, G.; Li, A. P.; LeCluyse, E.; Groothuis, G. M.; Hengstler, J. G. Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab. Rev. 2007, 39 (1), 159-234.
18. McCracken, N. W.; Blain, P. G.; Williams, F. M. Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. Biochem. Pharmacol. 1993, 45 (1), 31-6.
19. Padilla, S. Regulatory and research issues related to Cholinesterase inhibition. Toxicology 1995, 102 (1-2), 215-20.
20. McDaniel, K. L.; Padilla, S.; Marshall, R. S.; Phillips, P. M.; Podhorniak, L.; Qian, Y.; Moser, V. C. Comparison of acute neurobehavioral and Cholinesterase inhibitory effects of N-methylcarbamates in rat. Toxicol. Sei. 2007, 98 (2), 552-60.
21. Main, A. R. Kinetics of Cholinesterase inhibition by organophosphate and carbamate insecticides. Can. Med. Assoc. J. 1969, 700(4), 161-7.
22. Aldunate, R.; Casar, J. C.; Brandan, E.; Inestrosa, N. C. Structural and functional organization of synaptic acetylcholinesterase. Brain Res. Brain Res. Rev. 2004, 47 (1-3), 96-104.
23. Skau, K. A. Acetylcholinesterase molecular forms in serum and erythrocytes of laboratory animals. Comp. Biochem. Physiol, Part C 1985, 80 (1), 207-10.
24. Kousba, A. Letter to the Editor. Toxicol. Sei. 2007.
25. Blaauboer, B. J. Biokinetic modeling and in vitro-in vivo extrapolations. J. Toxicol. Environ. Health, Part B 2010, 13 (2-4), 242-52.
26. Yan, G. Z.; Brouwer, K. L.; Pollack, G. M.; Wang, M. Z.; Tidwell, R. R.; Hall, J. E.; Paine, M. F. Mechanisms underlying differences in systemic exposure of structurally similar active metabolites: Comparison of two preclinical hepatic models. J. Pharmacol. Exp. Ther 2011, 337(2), 503-12.
27. Roberts, W. L.; Kim, B. H.; Rosenberry, T. L. Differences in the glycolipid membrane anchors of bovine and human erythrocyte acetylcholinesterases. Proc. Natl. Acad. Sei. U.S.A. 1987, 84 (22), 7817-21.
28. May, D. G.; Naukam, R. J.; Kambam, J. R.; Branch, R. A. Cimetidine-carbaryl interaction in humans: Evidence for an active metabolite of carbaryl. J. Pharmacol. Exp. Ther. 1992, 262 (3), 1057-61.
29. Pekas, J. C. Gastrointestinal metabolism and transport of pesticidal carbamates. Crit. Rev. Toxicol. 1980, 7(1), 37-101.
30. Houston, J. B.; Upshall, D. G.; Bridges, J. W. Pharmacokinetics and metabolism of two carbamate insecticides, carbaryl and landrin, in the rat. Xenobiotica 1975, 5 (10), 637-48.
31. Shen, D. D.; Kunze, K. L.; Thummel, K. E. Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction. Adv. Drug Delivery Rev. 1997, 27 (2-3), 99-127.
32. Paine, M. F.; Hart, H. L.; Ludington, S. S.; Haining, R. L.; Rettie, A. E.; Zeldin, D. C. The human intestinal cytochrome P450 "pie". Drug Me tab. Dispos. 2006, 34 (5), 880-6.
33. Imai, T.; Imoto, M.; Sakamoto, H.; Hashimoto, M. Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption. Drug Metab. Dispos. 2005, 33 (8), 1185-90.